Urgent Recall! 1,348 Bottles of Salmonella-Contaminated Dietary Supplements from Gorilla Mind LLC Recalled, Consumers Face Serious Health Risks
On October 17, 2024, the U.S. Food and Drug Administration (FDA) officially notified that Gorilla Mind LLC has voluntarily recalled a total of 1,348 bottles of dietary supplements that may present a risk of Salmonella contamination, according to Food Safety News Network. The recall involves Rauwolscine Dietary, manufactured in lot 24041003, which has a shelf life until April 2026 and has been widely distributed throughout the country.
The recall, which began on September 6, 2024, is ongoing. The US FDA solemnly warns consumers not to continue to eat the above batch of products, and recommends that the purchased products be returned to the original purchase channel for a full refund.
In light of the potential hazard of salmonella contamination, Gorilla Mind LLC of Boise, Idaho has officially initiated a recall process for Rauwolscine dietary supplements. According to the detailed information released by the FDA, the recall began on September 6 and has not yet been completed.
It is important to note that foods contaminated with Salmonella may not have a significant change in appearance, smell, or taste. As a result, anyone who eats contaminated food is at risk, especially infants, children, the elderly and people with weakened immune systems, who are at significantly increased risk of serious illness.
In particular, the Centers for Disease Control and Prevention says people who have eaten the recalled products and show symptoms of possible salmonella infection should seek medical attention immediately and talk to their doctor about possible salmonella exposure. Because the symptoms of salmonella infection can be similar to other illnesses, a professional test is needed to confirm the diagnosis.
Specifically, symptoms of salmonella infection usually appear within 12 to 72 hours of eating contaminated food, including diarrhea, abdominal cramps, and fever. Although healthy adults generally recover on their own within four to seven days, in some cases diarrhea can be so severe that hospitalization is required.
In addition, high-risk groups such as the elderly, children, pregnant women, and people with compromised immune systems, such as cancer patients, are more likely to develop serious and even life-threatening diseases. It is important to note that even if some people do not show obvious symptoms after infection, they can still become a transmitter of Salmonella.
In response to this recall, we again emphasize that the product in question is Rauwolscine Dietary, manufactured with lot number 24041003, shelf life until April 2026, and a total of 1,348 bottles. We urge consumers to immediately stop using this product and properly dispose of the recalled products to prevent their continued circulation.
We are also asking retailers to quickly check inventory, isolate and flag products that need to be recalled. If the product has been sold or distributed, it is important to identify and immediately notify the relevant customer of the recall.
2026-09-10
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Global Countries Impose Tariffs on Chinese Chemical Products
-
Rare Earth and Power: Strategic Probing Beneath the New U.S.–China Trade Framework
-
U.S. Chemical Tariff Deadline Nears as the Industry Faces Cost Repricing and Supply-Chain Adjustment
-
EU Finalizes Anti-Dumping Duties on Chinese Adipic Acid as Chemical Trade Enters a Rule-Intensive Phase
-
EU Biocidal Data Protection Extension Raises the Stakes for Chemical Market Entry
-
China's National Narcotics Control Commission Issues Important Notice: Beware of These 8 Chemicals Being Diverted for Drug Production
-
API Supplier Audits Move to the Center of Pharma Supply Resilience
-
Supplement Recall Puts Nutrition Ingredient Safety Back Under Pressure
-
Chemours Sells Its Former Titanium Dioxide Site in Taiwan: Turning a “White Powder” Factory into “Wind Power Real Estate” for $360 Million—Buying Not Cash, But Breathing Room
-
The “Counter-Wind Ledger” of CHF 11.2 Billion: Sika Barely Grew in 2025—Yet Kept Taking Market Share
Recommend Reading
-
The Capital Undercurrent in the Desert: China’s Banks, Saudi Gas, and the “Absent” Chinese Funds
-
Solvay’s Zhenjiang Plant Expansion Goes Online, Doubling Electronic-Grade Hydrogen Peroxide Output to Support Semiconductor Advancements
-
ExxonMobil “Hits the Brakes”: Industrial Fractures Under the EU’s Chemical Recycling Policy Reef
-
When Soybeans Lose Weight, Fertilizers Take the Stage: The Industrial Chain Reaction Behind U.S. Farm Subsidies
-
Sun Pharma’s Winning Formula: Precision Over Expansion
-
Business Society’s September 4, 2026 Acetone Market Outlook: Operating at High Levels
-
Change Rate Remains Negative, This Round of Refined Oil Retail Prices in China Will Be Reduced
-
Business Society’s Market Outlook for Acrylic Acid on September 4, 2026: Fluctuating Trend
-
Business Society’s August 14, 2026 Melamine Market Outlook: Clearly Downward
-
Business Society’s Market Outlook for Epoxy Resins on September 4, 2026: Stable Operation